European directive has doubled cost of running trials in UKBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39055.352905.DB (Published 07 December 2006) Cite this as: BMJ 2006;333:1190
- Roger Dobson
New European regulations have delayed non-commercial trials in the United Kingdom relating to cancer and doubled the cost of running them, a new study says.
The European Union's clinical trials directive has stopped most clinical trials units in the UK from running trials in international centres, and three out of eight units have been unable to open or take part in a trial because it would be too difficult or expensive for them, says the study, which was published online ahead of print publication on 21 November in the European Journal of Cancer (www.sciencedirect.com, doi: 10.1016/j.ejca.2006.09.016).
“Rather than …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial